{"id":"https://openalex.org/W2385703614","doi":"https://doi.org/10.1186/s13195-016-0189-7","title":"Bapineuzumab for mild to moderate Alzheimer\u2019s disease in two global, randomized, phase 3 trials","display_name":"Bapineuzumab for mild to moderate Alzheimer\u2019s disease in two global, randomized, phase 3 trials","publication_year":2016,"publication_date":"2016-05-12","ids":{"openalex":"https://openalex.org/W2385703614","doi":"https://doi.org/10.1186/s13195-016-0189-7","mag":"2385703614","pmid":"https://pubmed.ncbi.nlm.nih.gov/27176461","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4866415"},"language":"en","primary_location":{"id":"doi:10.1186/s13195-016-0189-7","doi":"https://doi.org/10.1186/s13195-016-0189-7","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13195-016-0189-7","pdf_url":"https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-016-0189-7","source":{"id":"https://openalex.org/S140755874","display_name":"Alzheimer s Research & Therapy","issn_l":"1758-9193","issn":["1758-9193"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's Research & Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-016-0189-7","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071341444","display_name":"Rik R. Vandenberghe","orcid":"https://orcid.org/0000-0001-6237-2502","observed_orcids":["https://orcid.org/0000-0001-6237-2502"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Rik Vandenberghe","raw_affiliation_strings":["University Hospitals Leuven, Department of Neurosciences, Alzheimer Research Centre KU Leuven, Herestraat 49, 3000, Leuven, Belgium. rik.vandenberghe@uzleuven.be","University Hospitals Leuven, Department of Neurosciences, Alzheimer Research Centre KU Leuven, Herestraat 49, 3000, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Leuven, Department of Neurosciences, Alzheimer Research Centre KU Leuven, Herestraat 49, 3000, Leuven, Belgium. rik.vandenberghe@uzleuven.be","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"University Hospitals Leuven, Department of Neurosciences, Alzheimer Research Centre KU Leuven, Herestraat 49, 3000, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087888043","display_name":"Juha O. Rinne","orcid":"https://orcid.org/0000-0001-6369-0764","observed_orcids":["https://orcid.org/0000-0001-6369-0764"]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]},{"id":"https://openalex.org/I2801970007","display_name":"Turku University Hospital","ror":"https://ror.org/05dbzj528","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2801970007","https://openalex.org/I4210127022"]},{"id":"https://openalex.org/I4210105428","display_name":"Turku PET Centre","ror":"https://ror.org/01761e930","country_code":"FI","type":"facility","lineage":["https://openalex.org/I130217899","https://openalex.org/I155660961","https://openalex.org/I2801970007","https://openalex.org/I4210105428","https://openalex.org/I4210127022"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Juha O. Rinne","raw_affiliation_strings":["Turku PET Centre and Division of Clinical Neurosciences, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20520, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Turku PET Centre and Division of Clinical Neurosciences, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20520, Turku, Finland","institution_ids":["https://openalex.org/I155660961","https://openalex.org/I2801970007","https://openalex.org/I4210105428"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050897246","display_name":"Mer\u00e7\u00e9 Boada","orcid":"https://orcid.org/0000-0003-2617-3009","observed_orcids":["https://orcid.org/0000-0003-2617-3009"]},"institutions":[{"id":"https://openalex.org/I4210124683","display_name":"Fundaci\u00f3 ACE","ror":"https://ror.org/02z2bdj68","country_code":"ES","type":"other","lineage":["https://openalex.org/I4210124683"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Merc\u00e8 Boada","raw_affiliation_strings":["Fundaci\u00f3 ACE, Barcelona Alzheimer Treatment and Research Center, Gran via de Carles III, 85 Bis, 08028, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3 ACE, Barcelona Alzheimer Treatment and Research Center, Gran via de Carles III, 85 Bis, 08028, Barcelona, Spain","institution_ids":["https://openalex.org/I4210124683"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113696911","display_name":"Sadao Katayama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I113306721","display_name":"Hiroshima University","ror":"https://ror.org/03t78wx29","country_code":"JP","type":"education","lineage":["https://openalex.org/I113306721"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Sadao Katayama","raw_affiliation_strings":["Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan","institution_ids":["https://openalex.org/I113306721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025870220","display_name":"Philip Scheltens","orcid":"https://orcid.org/0000-0002-1046-6408","observed_orcids":["https://orcid.org/0000-0002-1046-6408"]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Philip Scheltens","raw_affiliation_strings":["Alzheimercentrum VUmc, Neurology, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alzheimercentrum VUmc, Neurology, VU University Medical Center, PO Box 7057, 1007, MB, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049484291","display_name":"Bruno J. Vellas","orcid":"https://orcid.org/0000-0002-7678-5065","observed_orcids":["https://orcid.org/0000-0002-7678-5065","https://orcid.org/0009-0004-5560-1898"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bruno Vellas","raw_affiliation_strings":["CHU Toulouse, G\u00e9rontop\u00f4le, 170 Avenue de Casselardit, TSA 40031, 31059, Toulouse, Cedex 9, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Toulouse, G\u00e9rontop\u00f4le, 170 Avenue de Casselardit, TSA 40031, 31059, Toulouse, Cedex 9, France","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111878869","display_name":"Michael M. Tuchman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143151","display_name":"Palm Beach Neurological Center","ror":"https://ror.org/04v2tad62","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Tuchman","raw_affiliation_strings":["Palm Beach Neurological Center, 3365 Burns Road, Suite 203, Palm Beach Gardens, FL, 33410, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Palm Beach Neurological Center, 3365 Burns Road, Suite 203, Palm Beach Gardens, FL, 33410, USA","institution_ids":["https://openalex.org/I4210143151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020136275","display_name":"Achim Gass","orcid":"https://orcid.org/0000-0003-0294-2555","observed_orcids":["https://orcid.org/0000-0003-0294-2555"]},"institutions":[{"id":"https://openalex.org/I4210156450","display_name":"University Medical Centre Mannheim","ror":"https://ror.org/05sxbyd35","country_code":"DE","type":"funder","lineage":["https://openalex.org/I4210156450"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Achim Gass","raw_affiliation_strings":["Department of Neurology, University Hospital Mannheim, University Medical Centre Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University Hospital Mannheim, University Medical Centre Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany","institution_ids":["https://openalex.org/I4210156450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087508465","display_name":"Jochen B. Fiebach","orcid":"https://orcid.org/0000-0002-7936-6958","observed_orcids":["https://orcid.org/0000-0002-7936-6958"]},"institutions":[{"id":"https://openalex.org/I4405268574","display_name":"Center for Stroke Research Berlin","ror":"https://ror.org/01cr98995","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4405268574"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jochen B. Fiebach","raw_affiliation_strings":["Center for Stroke Research Berlin (CSB), Charit\u00e9 Universit\u00e4tsmedizin Berlin, Hindenburgdamm 30, 12200, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Stroke Research Berlin (CSB), Charit\u00e9 Universit\u00e4tsmedizin Berlin, Hindenburgdamm 30, 12200, Berlin, Germany","institution_ids":["https://openalex.org/I4405268574","https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101829131","display_name":"David Hill","orcid":"https://orcid.org/0000-0003-1970-1432","observed_orcids":["https://orcid.org/0000-0003-1970-1432"]},"institutions":[{"id":"https://openalex.org/I4210096995","display_name":"Ixico (United Kingdom)","ror":"https://ror.org/00paezp73","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210096995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Derek Hill","raw_affiliation_strings":["IXICO Ltd., The London Bioscience Innovation Centre, 4th Floor, Griffin Court, 15 Long Lane, London, EC1A 9PN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IXICO Ltd., The London Bioscience Innovation Centre, 4th Floor, Griffin Court, 15 Long Lane, London, EC1A 9PN, UK","institution_ids":["https://openalex.org/I4210096995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061039783","display_name":"Kasia Lobello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kasia Lobello","raw_affiliation_strings":["Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100432955","display_name":"David Xinzheyang Li","orcid":"https://orcid.org/0000-0002-1028-8445","observed_orcids":["https://orcid.org/0000-0002-1028-8445"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Li","raw_affiliation_strings":["Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020866326","display_name":"Tom McRae","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom McRae","raw_affiliation_strings":["Pfizer Inc., 235 East 42nd Street, New York, NY, 10017, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., 235 East 42nd Street, New York, NY, 10017, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083343966","display_name":"Prisca Lucas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118061","display_name":"Pfizer (France)","ror":"https://ror.org/02c9yny10","country_code":"FR","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210118061"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Prisca Lucas","raw_affiliation_strings":["Pfizer Global Research and Development (PGRD), 23-25 avenue Du Docteur Lannelongue, Paris, \u00cele-De-France, 75014, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development (PGRD), 23-25 avenue Du Docteur Lannelongue, Paris, \u00cele-De-France, 75014, France","institution_ids":["https://openalex.org/I4210118061"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Iona Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Iona Evans","raw_affiliation_strings":["Pfizer Ltd., Walton Oaks, Dorking Road, Tadworth, Surrey, KT20 7NS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd., Walton Oaks, Dorking Road, Tadworth, Surrey, KT20 7NS, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043338100","display_name":"Kevin Booth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Booth","raw_affiliation_strings":["Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017541810","display_name":"G\u00e9rald Luscan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118061","display_name":"Pfizer (France)","ror":"https://ror.org/02c9yny10","country_code":"FR","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210118061"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gerald Luscan","raw_affiliation_strings":["Pfizer Global Research and Development (PGRD), 23-25 avenue Du Docteur Lannelongue, Paris, \u00cele-De-France, 75014, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Research and Development (PGRD), 23-25 avenue Du Docteur Lannelongue, Paris, \u00cele-De-France, 75014, France","institution_ids":["https://openalex.org/I4210118061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012191847","display_name":"Bradley T. Wyman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley T. Wyman","raw_affiliation_strings":["Pfizer Inc., 7 Kings Highway, Groton, CT, 06340, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., 7 Kings Highway, Groton, CT, 06340, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091783652","display_name":"Lisa Hua","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Hua","raw_affiliation_strings":["Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016385021","display_name":"Lingfeng Yang","orcid":"https://orcid.org/0000-0001-8451-7848","observed_orcids":["https://orcid.org/0000-0001-8451-7848","https://orcid.org/0009-0009-4020-700X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lingfeng Yang","raw_affiliation_strings":["Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009252002","display_name":"H. Robert Brashear","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405278923","display_name":"Janssen Alzheimer Immunotherapy Research & Development (United States)","ror":"https://ror.org/00rvg4q19","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405278923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Robert Brashear","raw_affiliation_strings":["Janssen Alzheimer Immunotherapy Research & Development, LLC, 700 Gateway Boulevard, South San Francisco, CA, 94080, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Alzheimer Immunotherapy Research & Development, LLC, 700 Gateway Boulevard, South San Francisco, CA, 94080, USA","institution_ids":["https://openalex.org/I4405278923"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109165894","display_name":"Ronald S. Black","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald S. Black","raw_affiliation_strings":["Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":17,"corresponding_author_ids":["https://openalex.org/A5071341444"],"corresponding_institution_ids":["https://openalex.org/I99464096"],"apc_list":{"value":4290,"currency":"USD","value_usd":4290},"apc_paid":{"value":4290,"currency":"USD","value_usd":4290},"fwci":12.8874,"has_fulltext":true,"cited_by_count":314,"citation_normalized_percentile":{"value":0.99550641,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"8","issue":"1","first_page":"18","last_page":"18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bapineuzumab","display_name":"bapineuzumab","score":1.0},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/anti-amyloid-therapy","display_name":"anti-amyloid therapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/amyloid-related-imaging-abnormalities","display_name":"amyloid-related imaging abnormalities","score":0.8389999866485596},{"id":"https://openalex.org/keywords/amyloid-load","display_name":"amyloid load","score":0.7799999713897705},{"id":"https://openalex.org/keywords/phosphorylated-tau","display_name":"phosphorylated tau","score":0.8759999871253967},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.6890000104904175},{"id":"https://openalex.org/keywords/disability","display_name":"disability","score":0.5080000162124634},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5830000042915344},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8105103969573975},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6785439252853394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.658431887626648},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5898833870887756},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5865834355354309},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5469366312026978},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.502227783203125},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.49137893319129944},{"id":"https://openalex.org/C16568411","wikidata":"https://www.wikidata.org/wiki/Q83042","display_name":"Neurology","level":2,"score":0.4388197064399719},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.431274950504303},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.4223657250404358},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4020461142063141},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35717329382896423},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.19590124487876892},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.16210561990737915},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016875","descriptor_name":"tau Proteins","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053327","descriptor_name":"Apolipoprotein E4","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":10,"locations":[{"id":"doi:10.1186/s13195-016-0189-7","doi":"https://doi.org/10.1186/s13195-016-0189-7","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13195-016-0189-7","pdf_url":"https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-016-0189-7","source":{"id":"https://openalex.org/S140755874","display_name":"Alzheimer s Research & Therapy","issn_l":"1758-9193","issn":["1758-9193"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's Research & Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4866415","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4866415","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimers Res Ther","raw_type":"Text"},{"id":"pmid:27176461","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27176461","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's research & therapy","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/523d5332-63ee-442d-a075-aa0d5e9897bb","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/523d5332-63ee-442d-a075-aa0d5e9897bb","pdf_url":null,"source":{"id":"https://openalex.org/S7407055350","display_name":"Amsterdam UMC (VU Amsterdam) - Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/91d63601-c74e-49fa-81ac-4ad8363062c3","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/91d63601-c74e-49fa-81ac-4ad8363062c3","pdf_url":"https://pure.amsterdamumc.nl/ws/files/159881237/Bapineuzumab-for-mild-to-moderate-alzheimers-disease-in-two-global-randomized-phase-3-trials.pdf","source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Bapineuzumab 3000 and 3001 Clinical Study Investigators 2016, 'Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials', ALZHEIMERS RESEARCH & THERAPY, vol. 8, no. 1, 18. https://doi.org/10.1186/s13195-016-0189-7","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/563578","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/563578","pdf_url":"https://lirias.kuleuven.be/retrieve/f95688cd-2e2a-4daf-89c5-0ae0ee676faa","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Alzheimer's Research & Therapy, vol. 8 (18), Art.No. ARTN 18, (1-13)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:10064547","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/10064547/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Alzheimer's Research & Therapy , 8 , Article 18. (2016)","raw_type":"Article"},{"id":"pmh:oai:refubium.fu-berlin.de:fub188/15229","doi":null,"is_oa":true,"landing_page_url":"https://refubium.fu-berlin.de/handle/fub188/15229","pdf_url":null,"source":{"id":"https://openalex.org/S4306402444","display_name":"Refubium (Universit\u00e4tsbibliothek der Freien Universit\u00e4t Berlin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I75951250","host_organization_name":"Freie Universit\u00e4t Berlin","host_organization_lineage":["https://openalex.org/I75951250"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Wissenschaftlicher Artikel"},{"id":"pmh:oai:www.utupub.fi:10024/168272","doi":null,"is_oa":false,"landing_page_url":"https://www.utupub.fi/handle/10024/168272","pdf_url":null,"source":{"id":"https://openalex.org/S4306402470","display_name":"UTUPub (University of Turku)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I155660961","host_organization_name":"University of Turku","host_organization_lineage":["https://openalex.org/I155660961"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},{"id":"pmh:vumc:oai:pure.atira.dk:publications/523d5332-63ee-442d-a075-aa0d5e9897bb","doi":null,"is_oa":false,"landing_page_url":"https://research.vumc.nl/en/publications/523d5332-63ee-442d-a075-aa0d5e9897bb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Alzheimer's Research & Therapy, 8(1):18. BioMed Central","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1186/s13195-016-0189-7","doi":"https://doi.org/10.1186/s13195-016-0189-7","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13195-016-0189-7","pdf_url":"https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-016-0189-7","source":{"id":"https://openalex.org/S140755874","display_name":"Alzheimer s Research & Therapy","issn_l":"1758-9193","issn":["1758-9193"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's Research & Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320337415","display_name":"Janssen Research and Development","ror":"https://ror.org/03qd7mz70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2385703614.pdf","grobid_xml":"https://content.openalex.org/works/W2385703614.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1824074994","https://openalex.org/W1980564700","https://openalex.org/W1992474532","https://openalex.org/W2004535959","https://openalex.org/W2015484447","https://openalex.org/W2053936304","https://openalex.org/W2063808031","https://openalex.org/W2086572083","https://openalex.org/W2108216694","https://openalex.org/W2116456562","https://openalex.org/W2150231759","https://openalex.org/W2171051792"],"related_works":["https://openalex.org/W2063808031","https://openalex.org/W7138209290","https://openalex.org/W2423611370","https://openalex.org/W2086572083","https://openalex.org/W6958548144","https://openalex.org/W4248911021","https://openalex.org/W6957668881","https://openalex.org/W2888012765","https://openalex.org/W7138365538","https://openalex.org/W2065877779"],"abstract_inverted_index":{"BACKGROUND:":[0],"Our":[1],"objective":[2],"was":[3],"to":[4,20,73,111,201],"evaluate":[5],"the":[6,77,85,99,116,138,161,174,207,214],"efficacy":[7,114,188],"(clinical":[8],"and":[9,11,46,84,95,102,135,141],"biomarker)":[10],"safety":[12],"of":[13,27,93,113,122,144,187,189],"intravenous":[14],"bapineuzumab":[15,52,123,134,145,190,218],"in":[16,41,48,115,124,160,197,206],"patients":[17,97,198],"with":[18,167,199,213],"mild":[19,200],"moderate":[21,202],"Alzheimer's":[22,79],"disease":[23],"(AD).":[24],"METHODS:":[25],"Two":[26],"four":[28],"phase":[29,119,181,216],"3,":[30],"multicenter,":[31],"randomized,":[32],"double-blind,":[33],"placebo-controlled,":[34],"18-month":[35],"trials":[36,121,128,184],"were":[37,69,107,156,171,210,224],"conducted":[38],"globally:":[39],"one":[40],"apolipoprotein":[42],"E":[43],"\u03b54":[44],"carriers":[45],"another":[47],"noncarriers.":[49],"Patients":[50],"received":[51],"0.5":[53],"mg/kg":[54,59],"(both":[55],"trials)":[56],"or":[57,62,149,169],"1.0":[58],"(noncarrier":[60],"trial)":[61],"placebo":[63,136,162],"every":[64],"13":[65],"weeks.":[66],"Coprimary":[67],"endpoints":[68,140,196],"change":[70],"from":[71],"baseline":[72],"week":[74],"78":[75],"on":[76,146,194],"11-item":[78],"Disease":[80],"Assessment":[81,87],"Scale-Cognitive":[82],"subscale":[83],"Disability":[86],"for":[88,137],"Dementia.":[89],"RESULTS:":[90],"A":[91],"total":[92],"683":[94],"329":[96],"completed":[98],"current":[100,127],"carrier":[101],"noncarrier":[103],"trials,":[104],"respectively,":[105],"which":[106],"terminated":[108],"prematurely":[109],"owing":[110],"lack":[112,186],"two":[117],"other":[118,215],"3":[120,182,217],"AD.":[125,203],"The":[126],"showed":[129],"no":[130,142],"significant":[131],"difference":[132],"between":[133],"coprimary":[139],"effect":[143],"amyloid":[147],"load":[148],"cerebrospinal":[150],"fluid":[151],"phosphorylated":[152],"tau.":[153],"(Both":[154],"measures":[155],"stable":[157],"over":[158],"time":[159],"group.)":[163],"Amyloid-related":[164],"imaging":[165],"abnormalities":[166],"edema":[168],"effusion":[170],"confirmed":[172,185],"as":[173],"most":[175],"notable":[176],"adverse":[177,222],"event.":[178],"CONCLUSIONS:":[179],"These":[180],"global":[183],"at":[191],"tested":[192],"doses":[193],"clinical":[195],"Some":[204],"differences":[205],"biomarker":[208],"results":[209],"seen":[211],"compared":[212],"trials.":[219],"No":[220],"unexpected":[221],"events":[223],"observed.":[225],"TRIAL":[226],"REGISTRATION:":[227],"Noncarriers":[228],"(3000)":[229],"ClinicalTrials.gov":[230,240],"identifier":[231,241],"NCT00667810":[232],";":[233,243],"registered":[234,244],"24":[235],"Apr":[236],"2008.":[237,247],"Carriers":[238],"(3001)":[239],"NCT00676143":[242],"2":[245],"May":[246]},"counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":26},{"year":2024,"cited_by_count":38},{"year":2023,"cited_by_count":37},{"year":2022,"cited_by_count":26},{"year":2021,"cited_by_count":37},{"year":2020,"cited_by_count":38},{"year":2019,"cited_by_count":29},{"year":2018,"cited_by_count":44},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}